References

Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006

10.1038/sj.bjc.6605883 · 2010 · External reference

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States

10.1002/cncr.27772 · 2013 · External reference

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen

10.1002/1097-0142(19841001)54:7<1264::aid-cncr2820540706>3.0.co;2-r · 1984 · External reference

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

10.1093/eurheartj/ehw211 · 2016 · External reference

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

10.1111/j.1538-7836.2007.02374.x · 2007 · External reference

Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma

10.1007/s10147-019-01464-4 · 2019 · External reference

The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma

10.4065/80.12.1568 · 2005 · External reference

The changes of blood platelet activation in breast cancer patients before surgery, after surgery, and in various phases of the chemotherapy

10.3109/09537104.2012.711866 · 2013 · External reference

Doxorubicin-induced platelet procoagulant activities: an important clue for chemotherapy-associated thrombosis

10.1093/toxsci/kfr222 · 2011 · External reference

Doxorubicin-induced platelet cytotoxicity: a new contributory factor for doxorubicin-mediated thrombocytopenia

10.1111/j.1538-7836.2009.03477.x · 2009 · External reference

Doxorubicin contributes to thrombus formation and vascular injury by interfering with platelet function

10.1152/ajpheart.00456.2019 · 2020 · External reference

Paper-Based Microfluidic Device (DON-Chip) for Rapid and Low-Cost Deoxynivalenol Quantification in Food, Feed, and Feed Ingredients

10.1021/acssensors.9b01895 · 2019 · External reference

Soil-on-a-Chip: microfluidic platforms for environmental organismal studies

10.1039/c5lc01285f · 2016 · External reference

New tools and new biology: Recent miniaturized systems for molecular and cellular biology

10.1007/s10059-013-0333-1 · 2013 · External reference

Organ-on-a-Chip Technology for Reproducing Multiorgan Physiology

10.1002/adhm.201700419 · 2018 · External reference

Ex Vivo Tumor-on-a-Chip Platforms to Study Intercellular Interactions within the Tumor Microenvironment

10.1002/adhm.201801198 · 2018 · External reference

Vasculature-On-A-Chip for In Vitro Disease Models

10.3390/bioengineering4010008 · 2017 · External reference

Mimicking arterial thrombosis in a 3D-printed microfluidic in vitro vascular model based on computed tomography angiography data

10.1039/c7lc00202e · 2017 · External reference

Microfluidic system for simultaneous optical measurement of platelet aggregation at multiple shear rates in whole blood

10.1039/c2lc21145a · 2012 · External reference

Platelet bioreactor-on-a-chip

10.1182/blood-2014-05-574913 · 2014 · External reference

Mechanisms and risk factors of thrombosis in cancer

10.1016/j.critrevonc.2017.08.003 · 2017 · External reference

Symptomatic Venous Thromboembolism in Cancer Patients Treated With Chemotherapy: An Underestimated Phenomenon

10.1001/archinte.164.2.190 · 2004 · External reference

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis

10.1001/jama.2008.656 · 2008 · External reference

Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

10.1200/jco.2009.27.2757 · 2010 · External reference

Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation

10.1073/pnas.95.14.8070 · 1998 · External reference

Advantages of Fast-Acting ADP Receptor Blockade in Ischemic Heart Disease

10.1161/01.atv.0000053387.06709.32 · 2003 · External reference

Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets

10.1111/j.1365-2141.1994.tb06736.x · 1994 · External reference

Platelet activation induced by a human neuroblastoma tumor cell line is reduced by prior administration of ticlopidine

10.1055/s-0038-1661558 · 1986 · External reference

Platelets

10.1016/s0140-6736(00)02175-9 · 2000 · External reference

A role for VEGF as a negative regulator of pericyte function and vessel maturation

10.1038/nature07424 · 2008 · External reference

Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin

10.1016/j.thromres.2007.06.015 · 2008 · External reference

Cancer stem cells contribute to angiogenesis and lymphangiogenesis in serous adenocarcinoma of the ovary

10.1007/s10456-019-09669-x · 2019 · External reference

EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis

10.1038/s41388-018-0565-9 · 2019 · External reference

Tumor angiogenesis and vascular normalization: alternative therapeutic targets

10.1007/s10456-017-9562-9 · 2017 · External reference

Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives

10.1007/s11684-012-0176-8 · 2012 · External reference

A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo

10.1084/jem.20020945 · 2003 · External reference

Platelet-collagen interaction: is GPVI the central receptor?

10.1182/blood-2002-12-3882 · 2003 · External reference

ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions

10.1182/blood-2002-05-1401 · 2002 · External reference

Von Willebrand factor, platelets and endothelial cell interactions

10.1046/j.1538-7836.2003.00260.x · 2003 · External reference

Biochemistry and genetics of von Willebrand factor

10.1146/annurev.biochem.67.1.395 · 1998 · External reference

Adhesion receptors of the immune system

10.1038/346425a0 · 1990 · External reference

Selectin ligands

10.1073/pnas.91.16.7390 · 1994 · External reference

The immune system and cardiac repair

10.1016/j.phrs.2008.06.007 · 2008 · External reference

Integrins as dynamic regulators of vascular function

10.1096/fasebj.8.12.7522194 · 1994 · External reference

Cell-based assays for profiling activity and safety properties of cancer drugs

10.1016/j.vascn.2006.02.014 · 2006 · External reference

Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms

10.1074/jbc.m400944200 · 2004 · External reference